The Australian flu became a significant public health concern during the past winter season. Coming shortly after the pandemic, it caused doubts and concern among the general public.
In the next sections, we’ll explore its key features and highlight comparisons with the virus behind the COVID-19 pandemic: SARS-CoV-2.
What Is the Australian Flu 2025 and Why Is It Relevant in Italy?
The 2025 Australian flu is a respiratory infection caused by the influenza A-H3N2 virus. Its geographically inspired name stems from the recent winter outbreak in Australia. In the following months, the virus spread to Italy during its cold season. The national epidemiological surveillance identified A-H3N2 as the most prevalent circulating influenza subtype.
Symptoms of Australian Flu: How to Recognize It
Symptoms of Australian flu depend on the specific action of the causative virus. Let’s look at its characteristics and its effects on the human body.
Pathogen: How It Differs from SARS-CoV-2
The Australian flu virus, like all influenza viruses, belongs to the Orthomyxoviridae family. Viruses are generally not considered living organisms as they lack a cellular structure. However, they carry genetic material (viral genome), which is replicable within the host. In this case, the genome is RNA-based, as is that of SARS-CoV-2. However, SARS-CoV-2 differs in other ways, belonging to the Coronaviridae family—hence the familiar name “Coronavirus.”
The Australian flu virus has long been recognized as a human pathogen capable of causing seasonal epidemics. Seasonal flu viruses are managed through periodically updated vaccination campaigns. SARS-CoV-2, by contrast, was new to humans and therefore capable of causing a pandemic, as it did. Today, vaccines are also available for COVID-19 management.
Transmission and Specific Symptoms
The Australian flu virus spreads through airborne droplets released during sneezing, coughing, or close conversations. It can also spread via contaminated surfaces, especially in poorly sanitized areas.
Symptoms include high fever, sore throat, nasal congestion, persistent cough, severe fatigue, and muscle and joint pain. In rare cases, it may also affect the central nervous system, with encephalitis being one of the most serious complications.
Duration and Course of Australian Flu 2025
Influenza A-H3N2 is typically self-limiting and short in duration. Most symptoms resolve within 5–7 days, though cough may persist for weeks. Severity varies by case, with greater impact on vulnerable or immunocompromised individuals. Sometimes, bacterial co-infections can complicate recovery and affect the respiratory tract.
Differential Diagnosis and Contagious Period
Since other seasonal viruses cause similar symptoms, immediate diagnosis can be challenging. With the spread of SARS-CoV-2, nasopharyngeal swabs are often used to confirm or rule out infection.
As for flu virus contagiousness, it typically begins one day before symptoms appear and lasts for about seven days after onset.
Treatment and Remedies for Australian Flu: What Science Says
A key concern is the misuse of antibiotics, which are only effective against bacterial infections and not viruses. If prescribed by a physician, symptomatic treatments or antivirals may be recommended.
When to Use Symptomatic and Antiviral Drugs
Symptomatic drugs help relieve symptoms. Paracetamol is widely used to reduce fever. NSAIDs, like ibuprofen, help with pain and inflammation. Other treatments include cough suppressants, expectorants, and nasal decongestants. Antiviral drugs may be used in specific cases, within 48 hours of symptom onset.
All drug use should be medically supervised to avoid potentially dangerous side effects.
Australian Flu vs COVID-19: Differences and Similarities
As mentioned, the Australian flu and COVID-19 share some similarities but also key differences.
Symptom Comparison
Many symptoms are similar, as both viruses affect the respiratory tract. Early COVID-19 cases often included severe respiratory difficulties. Notably, COVID-19 caused loss of taste and smell—even without nasal congestion—absent in flu cases, including Australian flu. One significant aspect unique to COVID-19 is Long COVID—a condition with lasting or delayed symptoms weeks after recovery. These may affect multiple systems: cardiovascular, respiratory, neurological, and more.
Duration, Severity, and Contagiousness
Current COVID-19 variants tend to cause short-lived symptoms. However, duration and severity vary by individual and depend on pre-existing conditions, age, and vaccine-induced immunity. While both viruses are highly contagious, COVID-19’s contagious period often lasts longer—even after symptom resolution.
When Is a Swab Test Needed?
Nasopharyngeal swabs help detect or exclude SARS-CoV-2 infection. They may be necessary, per medical advice, in complex cases, especially involving vulnerable groups like the elderly or immunocompromised.
Prevention, Vaccines, and Protective Devices: The COVID-19 Connection
Given what we’ve discussed about the Australian flu and COVID-19, let’s now focus on prevention.
Flu Vaccination: Who Should Get It and When
The flu vaccine is a key tool in primary prevention of seasonal epidemics. Administered in autumn, it is especially recommended for those at risk of complications, including pregnant women, the elderly, and chronically ill patients (e.g., with heart disease or cancer).
Note: The flu vaccine does not protect against SARS-CoV-2, which requires a specific vaccine.
Hygiene and Behavioral Best Practices
Certain hygiene practices can reduce infection risk. It’s important to wash hands regularly, ventilate indoor spaces, and avoid crowded, enclosed areas. If respiratory infection is suspected, self-isolation is encouraged to protect others. Responsible symptom management helps limit spread—like coughing into your elbow and using disposable tissues to blow your nose.
These practices apply broadly and help prevent all viral respiratory infections—including COVID-19.
Personal and Environmental Protection Devices
Effective viral infection prevention is enhanced by dedicated tools. These include personal respiratory protective equipment and environmental solutions.
Personal devices include face masks, categorized as “surgical” or “filtering facepieces.” The latter come in three protection levels: FFP1, FFP2, and FFP3. Their effectiveness depends on both filtering power and proper usage. Proper fit ensures maximum protection.
Environmental protection involves surface disinfection using chemical agents (e.g., ethanol, quaternary ammonium compounds) and physical methods like UV-C germicidal lamps. An increasingly popular option is electromagnetic field devices to inactivate airborne viruses. Among these, e4life protection devices stand out for improving indoor air quality and human health, in line with the “One Health” model.
